• LAST PRICE
    16.7900
  • TODAY'S CHANGE (%)
    Trending Up0.7000 (4.3505%)
  • Bid / Lots
    16.7900/ 3
  • Ask / Lots
    17.1100/ 1
  • Open / Previous Close
    16.6100 / 16.0900
  • Day Range
    Low 16.4800
    High 16.9750
  • 52 Week Range
    Low 14.3809
    High 24.8999
  • Volume
    150,059
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 16.09
TimeVolumeINDV
09:32 ET116116.52
09:38 ET76316.48
09:41 ET30016.49
09:43 ET40016.53
09:45 ET10016.49
09:48 ET420016.54
09:50 ET20016.56
09:54 ET34716.61
09:56 ET10016.58
09:59 ET348716.68
10:01 ET10016.67
10:03 ET10016.64
10:08 ET33916.66
10:12 ET10016.665
10:14 ET50016.64
10:15 ET76016.68
10:17 ET20016.705
10:19 ET81716.71
10:26 ET40016.68
10:30 ET10016.67
10:32 ET221516.76
10:35 ET40016.78
10:37 ET80016.78
10:39 ET1015416.8
10:42 ET83116.79
10:44 ET160016.77
10:46 ET143116.81
10:48 ET79316.8
10:50 ET23116.81
10:51 ET54616.84
10:53 ET20016.82
10:55 ET10016.84
11:00 ET83516.82
11:02 ET40016.83
11:09 ET70016.79
11:13 ET221516.88
11:15 ET60016.87
11:18 ET90016.88
11:22 ET30016.89
11:24 ET219116.91
11:26 ET60016.9191
11:27 ET50016.97
11:29 ET55816.975
11:33 ET10016.95
11:36 ET60016.87
11:42 ET12016.84
11:44 ET20016.85
11:45 ET10016.825
11:49 ET137616.77
11:51 ET30016.74
11:54 ET10016.74
11:58 ET30016.75
12:00 ET240016.73
12:02 ET50016.705
12:07 ET10016.709
12:09 ET40116.67
12:14 ET10016.709
12:20 ET10016.71
12:23 ET30016.65
12:25 ET20916.62
12:30 ET30016.615
12:32 ET20016.64
12:34 ET20016.61
12:38 ET30016.6
12:41 ET10016.62
12:48 ET20016.645
12:54 ET10016.649
12:56 ET10016.62
12:59 ET10016.65
01:03 ET10016.63
01:06 ET10016.61
01:08 ET30016.65
01:12 ET20016.66
01:14 ET20016.64
01:15 ET10016.68
01:17 ET10016.64
01:19 ET274316.73
01:21 ET10016.72
01:24 ET47016.721
01:26 ET10016.725
01:28 ET62916.71
01:30 ET10016.72
01:33 ET209616.769
01:35 ET10016.72
01:39 ET30016.755
01:42 ET30016.75
01:46 ET10016.75
01:48 ET10016.7
01:51 ET10016.75
01:57 ET61116.71
02:00 ET112816.65
02:02 ET30016.655
02:04 ET10016.655
02:06 ET60016.7
02:08 ET210016.7
02:09 ET20016.7
02:11 ET144916.765
02:13 ET202416.81
02:18 ET64416.79
02:20 ET146516.74
02:22 ET10016.72
02:24 ET10016.72
02:26 ET55516.72
02:27 ET147116.72
02:29 ET10016.74
02:31 ET335416.7
02:42 ET137116.725
02:44 ET123616.705
02:45 ET60016.67
02:47 ET10016.67
02:49 ET20016.67
02:51 ET20016.67
02:54 ET50016.66
02:56 ET30016.68
02:58 ET70016.675
03:00 ET20016.69
03:02 ET112916.7
03:03 ET50016.69
03:05 ET30016.705
03:07 ET10016.705
03:09 ET141016.675
03:12 ET20016.67
03:14 ET10016.67
03:16 ET20016.67
03:18 ET20016.685
03:20 ET30016.665
03:21 ET10016.65
03:23 ET40016.66
03:25 ET10016.67
03:27 ET30016.705
03:30 ET220016.71
03:32 ET54416.72
03:34 ET52316.705
03:36 ET50016.7
03:38 ET30716.71
03:39 ET153116.7
03:41 ET40016.7
03:43 ET103516.69
03:45 ET74316.7
03:48 ET60016.7
03:50 ET104016.69
03:52 ET140016.67
03:54 ET150016.7
03:56 ET179516.7
03:57 ET265716.715
03:59 ET352116.79
Data delayed at least 15 minutes.

Company Information

Indivior PLC is a pharmaceutical company. The Company develops medicines to treat addiction and serious mental illnesses. The Company focuses on building a portfolio of opioid dependence treatments. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Its product pipeline focuses on development and discovery of non-opioid treatment strategies for opioid use disorder (OUD), as well as therapies to address the needs of people suffering from alcohol, stimulant, and cannabis use disorders. Its Sublocade, Subutex, and Suboxone are used for the treatment of opioid use disorder (OUD). Perseris is used for the treatment of Schizophrenia. The Company's pipeline products include AEF0117, INDV-2000, INDV-1000, RBP-6000, RBP-7000, Buprenorphine Sublingual and Naloxone Film, and Buprenorphine and Naloxone Sublingual Tablet. Its pipeline also includes the Orexin-1 Receptor Antagonist Program.

Contact Information

Headquarters
10710 Midlothian Turnpike Suite 125, North ChesterfieldCHESTERFIELD, VA, United States 23235
Phone
804-379-1090
Fax
---

Executives

No data available

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$1.8B
Revenue (TTM)
$888.9M
Shares Outstanding
134.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
-0.17
EPS
$-0.02
Book Value
$0.00
P/E Ratio
407.5x
Price/Sales (TTM)
2.0
Price/Cash Flow (TTM)
69.8x
Operating Margin
0.36%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.